Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the ...

The global health community faces a deepening challenge—not only from infectious diseases but also from a pandemic of ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.

Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...

The new vaccinations could be self-administered at home, with the floss approach also thought compatible with flu, hepatitis ...

Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Robert F. Kennedy Jr. announces plans to reform the Vaccine Injury Compensation Program, addressing claims of inefficiency ...

Moderna (MRNA), once an unknown biotech firm, quickly rose to the top of the global vaccine market during the COVID-19 ...

Royal Caribbean (RCL) stock falls despite the company lifting its full-year outlook. Merck (MRK) stock is dipping after the company announced it will cut jobs as part of its larger cost-cutting plan.

CEO Rob Davis referred to the cost reduction program as a 'reallocation' rather than a cut, with the savings to be reinvested ...

We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...

HHS Secretary RFK Jr. vows to reform the Vaccine Injury Program, highlighting inefficiencies and favoritism in compensating ...